Bipolar Disorder Research Study for Ages 12 and Older
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The Bipolar Disorder Center for Pennsylvanians aims to reduce significant differences in
treatment results among Pennsylvanians with bipolar disorder, especially among youth, the
elderly, rural residents, and African Americans who are less likely to receive adequate
treatment, less likely to remain in treatment once identified, and less likely to have
positive results if they remain in treatment. Half of the subjects receive either Guideline
Intervention (GI) or Enhanced Clinical Intervention (ECI). ECI is a combination of
information and support, such as education about bipolar disorder, the medications used to
treat it, information about sleep practices and habits that affect quality of sleep, review
of symptoms, medication side effects, and coping with side effects. It is predicted that
Enhanced Clinical Intervention will be more effective in reducing the differences in results
between those most at risk compared to mid-life Caucasians. The treatment study occurs at
three sites across Pennsylvania and has emphasized the recruitment of African Americans,
youth (ages 12 through 18), and adults over age 65.
Phase:
N/A
Details
Lead Sponsor:
Kupfer, David J., M.D.
Collaborators:
Abbott Bristol-Myers Squibb Eli Lilly and Company GlaxoSmithKline Pfizer